8Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: A general strategy derived form fluoroquinolone studies [J]. Clin Inject Dis, 2001;33(Suppl 3):S147-156.
9EFFENDY I, LECHA M, FEUILHADE de CHAUVIN M,ct al. Onychomycosis observatory:epidemiology and clinical classification of onychomycosis [ J ]. J Eur Acad Dermatol Venereal,2005,19 ( Suppl 1 ) : 8 - 12.
10EVANS EGV. Resistance of Candida species to antifungal agents used in the treatment of onychomycosis : a review of current problems [ J ] British Journal of Dermatology, 1999,141 ( Supp1,56 ) : 33 - 35
1Kumar A, Mann HJ, Remmel RP. Simultaneous analysis of cytochrome P450 probe-dextromethorphan, flurbiprofen and midazolam and their major metabolites by HPLC-mass- spectrometry/fluorescence after single-step extraction from plasma [J]. J Chromatogr B Analyt Teehnol Biomed Life Sei, 2007, 853 (1-2) : 287-293.
2Ahonen J, Olkkola KT, Takala A, et al. Interaction between fluconazole and midazolam in intensive care patients [ J ]. Acta Anaesthesiol Seand, 1999, 43 (5) : 509-514.
